You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

November 8, 2013

Dr. Atthachai Homhuan Explains the Dark Side of Online Pharmacies in BigChilli Interview

The BigChilli

Ordering drugs from online pharmacies can be a risky ordeal. Not only can they cause serious harm to your health, but they may expose you to credit card fraud and put you in a difficult position with the Thai authorities. Dr. Atthachai Homhuan, manager of the Regulatory Affairs group at Tilleke & Gibbins, recently expressed his views on this subject in an interview arranged by The BigChilli magazine, in which he explained some of the pitfalls of dealing with online pharmacies.

The prevalence of online pharmacies in Thailand is growing. “Online pharmacy websites are extremely popular in Thailand with the booming of the Internet and the social media,” Atthachai says. “Illegal online websites originating in Thailand are offering drugs banned or restricted by the Thai Food and Drug Administration (FDA),” he continues. This is problematic, because “The drugs could be counterfeit, expired, or could go bad during transport, which may cause serious harm or even death.” On top of this, Atthachai warns that “customers are at risk of legal action being taken against them by the FDA or Customs if banned or restricted drugs addressed to them are found, for example at a post office.” Also, “Credit card information can be stolen because most of the people running illegal online pharmacies are criminals,” and, moreover, “minors can order controlled substances.” Online pharmacies present a huge problem in Thailand, and they need to be stopped.

Speaking on behalf of Tilleke & Gibbins, Atthachai says, “We coordinate with the patent-holding company and if we can find the source of the counterfeits, we inform them and help provide appropriate measures to prevent and eradicate the problem.” He continues, saying “We will contact the FDA through our Intellectual Property Department and try to work out a solution.” In closing, he says, “If you suspect you have been given a counterfeit product, contact the FDA or our law firm. We will contact the company that makes the legitimate product to investigate the matter. We are working closely with the FDA, and if we can overcome this problem we can improve the quality of life in Thailand.”

The BigChilli is a lifestyle, business, and educational magazine based in Thailand. If you would like to read the full interview, please visit The BigChilli website.

RELATED INSIGHTS​ 

October 13, 2016
Tilleke & Gibbins, together with EuroCham Vietnam, will hold a seminar focusing on legal issues in the pharmaceutical sector. The seminar will feature a panel of pharmaceutical and intellectual property experts from Japan, Thailand, and Vietnam, and it will provide attendees with an in-depth look at emerging issues in Vietnam’s rapidly developing pharmaceutical sector, including:
May 6, 2016
The key drivers of healthcare product investment are the effective protection of intellectual property rights and compliance with the law. Protection of IP rights and obtaining market authorization are challenges faced by every company operating in the healthcare industry. To discuss these issues and more, Dr. Atthachai Homhuan, regulatory affairs manager at Tilleke & Gibbins, will present on “Intellectual Property and Regulatory Perspectives of Thailand’s Healthcare Business” at an IP Lunch Talk held by Tilleke & Gibbins and the National Innovation Agency.
April 28, 2016
The nominees of Asian Legal Business’s Southeast Asia Law Awards 2016 have been announced, and Tilleke & Gibbins has secured nominations in three categories, as follows:Intellectual Property Firm of the YearThailand Law Firm of the YearVietnam Law Firm of the YearTo determine the winners, a team of researchers at ALB are considering factors such as firms’ breadth and complexity of work, innovation, third-party awards, and market feedback, among other criteria.